Life ScienceCompany
Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS Ownership
Who owns Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS?
Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS is owned by Strongbridge Biopharma. It was acquired on December 23, 2016.
Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS Business Overview
Where is Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS headquartered?
Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS is headquartered in Trevose, Pennsylvania.
What sector is Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS in?
Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.